Table 1.
Characteristic | N | Percentage |
---|---|---|
A. Gender | ||
Female | 37 | 68.5% |
Male | 17 | 31.5% |
B. Race | ||
Caucasian | 42 | 77.8% |
Black | 9 | 16.7% |
Hispanic | 2 | 3.7% |
Middle Eastern | 1 | 1.9% |
C. Iris color | ||
Hazel | 24 | 44.4% |
Brown | 20 | 37.0% |
Green | 6 | 11.1% |
Blue | 4 | 7.4% |
D. Medical history | ||
Cardiovascular arterial hypertension | 39 | 72.2% |
Cardiovascular lipid disorders | 25 | 46.3% |
Endocrine diabetes | 19 | 35.2% |
E. Opthalmic history | ||
Primary open-angle glaucoma | 35 | 64.8% |
Ocular hypertension | 16 | 29.6% |
Pigmentary glaucoma | 3 | 5.6% |
F. Glaucoma medication history | ||
Latanoprost 0.005% | 29 | 35.2% |
Travoprost 0.004% | 18 | 33.3% |
Bimatoprost 0.03% | 6 | 11.1% |
Mean number of glaucoma medications | 1.82 | |
Mean time on glaucoma medications (in years) | 12.56 | |
G. Eyes assigned to each medicine | ||
OD | ||
Test medication | ||
Latanaprost | 25 | 46.3% |
Travaprost BAK-free | 29 | 53.7% |
OS | ||
Latanaprost | 29 | 53.7% |
Travaprost BAK-free | 25 | 46.3% |